Dynocardia

There is an unmet need for accurate and continuous non-invasive blood pressure (cNIBP) monitoring. Problems stemming from inaccurate, intermittent (single-time-point) BP measurement and sub-therapeutic management of BP are particularly pronounced in hospitals, where currently, the only option for continuous measurement is the invasive intra-arterial catheter, which can lead to clinically significant complications. The other option, cuffed devices, provide only intermittent and often inaccurate BP readings.

Dynocardia’s proprietary ViTrack™ methodology is the technology behind ViTrack, a wrist- wearable device with the processing power to enable continuous beat-to-beat BP monitoring. ViTrack technology is poised to surmount century-old obstacles to obtaining accurate and continuous measurement of BP by enabling ambulatory and nocturnal measurement. Additionally, ViTrack technology holds great promise for improving outcomes in 1.5 billion people living with hypertension around the world, who are at heightened risk for stroke and heart attacks.

Dynocardia supports the UN Sustainable Development Goal 3: Good Health and Well-Being by advancing cardiovascular health through its innovative wearable technologies. Its platform provides continuous, non-invasive, and clinically accurate blood pressure monitoring, enabling earlier detection of risks, better disease management, and improved patient outcomes. By empowering both patients and healthcare providers with real-time insights, Dynocardia contributes to more effective prevention, diagnosis, and treatment of heart-related conditions worldwide.

“We are so grateful to 3DS for their interest in our work and investment in our efforts” says Dynocardia founder Mohan Thanikachalam, MD. We believe that their state-of-the-art prototyping facilities located here in Boston, along with 3DS’s product-development-software portfolio, automated platform for clinical trial recruitment, and strength of their engineering, IT, and design teams worldwide will allow us to commercialize ViTrack™ much faster than we’d have been able to otherwise.

Over the coming decade, ViTrack has the potential to monitor BP in billions of people and aggregate this real-world data in the cloud for unprecedented research opportunities for the prevention of cardiovascular disease. In addition to BP, ViTrack can provide heart rate, respiratory and other valuable cardio-hemodynamic data.